New York Life Investment Management’s Maravai LifeSciences MRVI Stock Holding History

New York Life Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,756	Closed	-$371K	–	1150
2024 Q1	$371K	Buy	42,756 +18,367	+75%	+$124K	﹤0.01%	965
2023 Q4	$160K	Sell	24,389 -1,025	-4%	-$6.62K	﹤0.01%	1299
2023 Q3	$254K	Sell	25,414 -4,003	-14%	-$44K	﹤0.01%	1236
2023 Q2	$366K	Sell	29,417 -5,218	-15%	-$70.4K	﹤0.01%	1120
2023 Q1	$485K	Buy	+34,635	New	+$497K	0.01%	791

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

New York Life Investment Management's MRVI Position: Q2 2024 in Review

New York Life Investment Management sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 42,756 shares — an estimated $371K sold.

New York Life Investment Management first reported a position in MRVI in Q1 2023 and held it in 5 quarters. The position peaked at $485K in Q1 2023. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

New York Life Investment Management reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
New York Life Investment Management sold 42,756 Maravai LifeSciences shares in Q2 2024, an estimated $371K.
New York Life Investment Management first reported a position in Maravai LifeSciences in Q1 2023 and held it in 5 quarters.
New York Life Investment Management's Maravai LifeSciences position peaked at $485K in Q1 2023.
206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.